Table 1.
Deviation Tail | Oedema | Malformation Head | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
120 hpf Experiment CBZ/E-CBZ |
# | Coagulation | No Hatching | Curve | Tissue Deviation |
Head | Pericardium | Yolk | Deviation Shape Head | Deviation Mouth | Deviation Eye | Deviation Pigmentation |
Swim Bladder Not Inflated |
EMS | 1 | 2/20 | 2/20 | 2/20 | 1/20 | ||||||||
2 | |||||||||||||
EMS 0.5% DMSO | 1 | 1/20 | 1/20 | 1/20 | |||||||||
2 | 1/20 | 1/20 | 2/20 | ||||||||||
EMS 1% DMSO | 1 | 1/20 | 2/20 | ||||||||||
2 | 1/20 | 1/20 | |||||||||||
CBZ 31.25 µM | 1 | 8/20 ** | |||||||||||
2 | 2/20 | ||||||||||||
CBZ 85 µM | 1 | 1/20 | 7/20 ** | ||||||||||
2 | 2/20 | 1/18 | 1/18 | 3/18 | 2/18 | 1/18 | 2/18 | ||||||
CBZ 250 µM | 1 | 5/20 * | 2/20 | 5/20 * | 3/20 | 4/20 | 5/20 * | 19/20 **** | 16/20 **** | ||||
2 | 1/20 | 2/20 | 4/20 | 3/20 | 3/20 | 3/20 | 8/20 ** | 18/20 **** | 11/20 ** | ||||
E-CBZ 250 µM | 1 | 1/20 | 1/20 | 1/20 | 1/20 | 3/20 | |||||||
2 | 1/20 | 1/20 | 1/20 | 6/20 * |
Ratios depicted in bold are statistically significant compared to the solvent control group.